SAM-based Genome Editing to Obtain Isogenic Cell Lines Overexpressing Human CD5 Protein

In vitro and in vivo experiments often require construction of convenient cell instruments to reliably assess the specificity of the molecules or therapeutic approaches being tested against the protein target of interest. Using model isogenic cell lines that differ only in the expression of the target protein represents an ideal solution to this problem. Cloning and efficient delivery of genetic cassettes encoding such proteins, particularly the large ones, is typically challenging, much as the knock-out of the respective genes. To tackle this issue, we adapted a CRISPR/ Cas9-based SAM (Synergistic Activation Mediator) platform, and successfully established four model isogenic cell line pairs (U343, HeLa, HT-1080 и HEp-2) overexpressing human CD5.

[1]  F. Végran,et al.  Alternative Splicing in Cancer and Immune Cells , 2022, Cancers.

[2]  Howard Y. Chang,et al.  Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing , 2021, Cell.

[3]  M. Brenner,et al.  Chimeric Antigen Receptors for T-Cell Malignancies , 2019, Front. Oncol..

[4]  Timothy E. Reddy,et al.  CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome , 2017, Nature Biotechnology.

[5]  D. Pezzoli,et al.  Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation , 2017, Scientific Reports.

[6]  Neville E Sanjana,et al.  Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening , 2016, Nature Protocols.

[7]  Antonia A. Dominguez,et al.  Transcriptional regulation of hepatic lipogenesis , 2015, Nature Reviews Molecular Cell Biology.

[8]  Christopher M. Vockley,et al.  Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers , 2015, Nature Biotechnology.

[9]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[10]  P. Bradding,et al.  CADM1 is expressed as multiple alternatively spliced functional and dysfunctional isoforms in human mast cells , 2013, Molecular immunology.

[11]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[12]  M. Kumar,et al.  Systematic determination of the packaging limit of lentiviral vectors. , 2001, Human gene therapy.